A Biogen Idec plant in Cambridge. There are more than 50 biotech licenses held by firms operating in the city.
(Essdras M Suarez/Globe Staff/File 2008)
CAMBRIDGE
Preventing a 'Resident Evil' scenario
Toomey concerned about biolab safety
A Biogen Idec plant in Cambridge. There are more than 50 biotech licenses held by firms operating in the city.
(Essdras M Suarez/Globe Staff/File 2008)
The premise of the latest "Resident Evil" movie, which was released late last month, may strike Cambridge residents as eerie: In a town called Harvardville (population 100,000), a biotech company called WilPharmaceuticals struggles to contain a deadly virus threatening to escape from its air-locked Level 4 laboratory. (Full article: 713 words)
This article is available in our archives:
Globe Subscribers
FREE for subscribers
Subscribers to the Boston Globe get unlimited access to our archives.
Not a subscriber?
Non-Subscribers
Purchase an electronic copy of the full article. Learn More
- $4.95 1 article
- $9.95 4 articles
- $25.95 Monthly
